Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients?

[1]  B. Riggs,et al.  Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel. , 1999, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[2]  R. Eastell,et al.  Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  P. Delmas,et al.  BIOCHEMICAL MARKERS OF BONE TURNOVER: Applications For Osteoporosis , 1998 .

[4]  P. Ross,et al.  Rapid Bone Loss Is Associated with Increased Levels of Biochemical Markers , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  S. Cummings,et al.  Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  W. O'Fallon,et al.  Relationship of Bone Turnover to Bone Density and Fractures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  C Marcelli,et al.  Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  L. Melton,et al.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. , 1996, Bone.

[9]  C. Christiansen,et al.  Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up Study , 1996 .

[10]  W. O'Fallon,et al.  Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  C. Christiansen,et al.  Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. , 2000, Bone.

[12]  L. Melton,et al.  The worldwide problem of osteoporosis: insights afforded by epidemiology. , 1995, Bone.

[13]  H K Genant,et al.  Axial and appendicular bone density predict fractures in older women , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  C. Slemenda,et al.  Baseline measurement of bone mass predicts fracture in white women. , 1989, Annals of internal medicine.

[15]  R. Parker,et al.  Early Changes in Biochemical Markers of Bone Turnover Predict the Long‐Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical Trial , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  P. Delmas,et al.  Monitoring individual response to hormone replacement therapy with bone markers. , 2000, Bone.

[17]  B. Drinkwater,et al.  Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. , 1997, The American journal of medicine.